☑ |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Delaware
|
20-0709285
|
|
(State or other jurisdiction of
Incorporation or organization)
|
(I.R.S. Employer
Identification No.)
|
|
5201 Interchange Way, Louisville, KY
|
40229
|
|
(Address of principal executive offices)
|
(Zip Code)
|
Large accelerated filer
|
☐ |
Accelerated filer
|
☑ | |||
Non-accelerated filer
|
☐ (Do not check if a smaller reporting company)
|
Smaller reporting company
|
☐ | |||
Emerging growth company
|
☑ |
Page No.
|
|||
PART I—FINANCIAL INFORMATION
|
|||
ITEM 1
|
Financial Statements (Unaudited)
|
||
5 |
|||
6 |
|||
7 |
|||
8 |
|||
9 |
|||
10
|
|||
12
|
|||
ITEM 2
|
32
|
||
ITEM 3
|
43
|
||
ITEM 4
|
43
|
||
PART II—OTHER INFORMATION
|
|||
ITEM 1
|
44
|
||
ITEM 1A
|
44
|
||
ITEM 2
|
44
|
||
ITEM 3
|
44
|
||
ITEM 4
|
44
|
||
ITEM 5
|
45
|
||
ITEM 6
|
45
|
||
46
|
· |
declining sales of tobacco products, and expected continuing decline of sales, in the tobacco industry overall;
|
· |
our dependence on a small number of third-party suppliers and producers;
|
· |
the possibility that we will be unable to identify or contract with new suppliers or producers in the event of a supply or product
disruption;
|
· |
the possibility that our licenses to use certain brands or trademarks will be terminated, challenged, or restricted;
|
· |
failure to maintain consumer brand recognition and loyalty of our customers;
|
· |
substantial and increasing U.S. regulation;
|
· |
regulation of our products by the Food and Drug Administration (the “FDA”), which has broad regulatory powers;
|
· |
uncertainty related to the regulation and taxation of our NewGen products;
|
· |
possible significant increases in federal, state, and local municipal tobacco-related taxes;
|
· |
possible increasing international control and regulation;
|
· |
our reliance on relationships with several large retailers and national chains for distribution of our products;
|
· |
our amount of indebtedness;
|
· |
the terms of our credit facilities, which may restrict our current and future operations;
|
· |
intense competition and our ability to compete effectively;
|
· |
uncertainty and continued evolution of markets containing our NewGen products;
|
· |
significant product liability litigation;
|
· |
the scientific community’s lack of information regarding the long-term health effects of electronic cigarette, vaporizer, and e-liquid
use;
|
· |
requirement to maintain compliance with Master Settlement Agreement escrow account requirements;
|
· |
competition from illicit sources;
|
· |
our reliance on information technology;
|
· |
security and privacy breaches;
|
· |
contamination of our tobacco supply or products;
|
· |
infringement on our intellectual property;
|
· |
third-party claims that we infringe on their intellectual property;
|
· |
failure to manage our growth;
|
· |
failure to successfully integrate our acquisitions or otherwise be unable to benefit from pursuing acquisitions;
|
· |
fluctuations in our results;
|
· |
exchange rate fluctuations;
|
· |
adverse U.S. and global economic conditions;
|
· |
sensitivity of end-customers to increased sales taxes and economic conditions;
|
· |
failure to comply with certain regulations;
|
· |
departure of key management personnel or our inability to attract and retain talent;
|
· |
imposition of significant tariffs on imports into the U.S.;
|
· |
reduced disclosure requirements applicable to emerging growth companies may make our common stock less attractive to investors,
potentially decreasing our stock price;
|
· |
failure to maintain our status as an emerging growth company before the five-year maximum time period a company may retain such status;
|
· |
our principal stockholders will be able to exert significant influence over matters submitted to our stockholders and may take certain
actions to prevent takeovers;
|
· |
our certificate of incorporation and bylaws, as well as Delaware law and certain regulations, could discourage or prohibit acquisition
bids or merger proposals which may adversely affect the market price of our common stock;
|
· |
our certificate of incorporation limits the ownership of our common stock by individuals and entities that are Restricted Investors.
These restrictions may affect the liquidity of our common stock and may result in Restricted Investors being required to sell or redeem their shares at a loss or relinquish their voting, dividend, and distribution rights;
|
· |
future sales of our common stock in the public market could reduce our stock price, and any additional capital raised by us through the
sale of equity or convertible securities may dilute your ownership in us;
|
· |
we may issue preferred stock whose terms could adversely affect the voting power or value of our common stock; and
|
· |
our status as a “controlled company” could make our common stock less attractive to some investors or otherwise harm our stock price.
|
ASSETS
|
(unaudited)
September 30, |
December 31,
2017 |
||||||
Current assets:
|
||||||||
Cash
|
$
|
1,631
|
$
|
2,607
|
||||
Accounts receivable, net of allowances of $44 in 2018 and $17 in 2017
|
6,603
|
3,248
|
||||||
Inventories
|
89,433
|
63,296
|
||||||
Other current assets
|
14,556
|
10,342
|
||||||
Total current assets
|
112,223
|
79,493
|
||||||
Property, plant, and equipment, net
|
10,585
|
8,859
|
||||||
Deferred income taxes
|
-
|
450
|
||||||
Deferred financing costs, net
|
922
|
630
|
||||||
Goodwill
|
146,328
|
134,620
|
||||||
Other intangible assets, net
|
35,140
|
26,436
|
||||||
Master Settlement Agreement (MSA) escrow deposits
|
29,926
|
30,826
|
||||||
Other assets
|
1,207
|
963
|
||||||
Total assets
|
$
|
336,331
|
$
|
282,277
|
||||
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
||||||||
Current liabilities:
|
||||||||
Accounts payable
|
$
|
8,760
|
$
|
3,686
|
||||
Accrued liabilities
|
17,401
|
18,694
|
||||||
Current portion of long-term debt
|
8,000
|
7,850
|
||||||
Revolving credit facility
|
30,000
|
8,000
|
||||||
Total current liabilities
|
64,161
|
38,230
|
||||||
Notes payable and long-term debt
|
188,529
|
186,190
|
||||||
Deferred income taxes
|
2,178
|
-
|
||||||
Postretirement benefits
|
3,916
|
3,962
|
||||||
Other long-term liabilities
|
558
|
571
|
||||||
Total liabilities
|
259,342
|
228,953
|
||||||
Commitments and contingencies
|
||||||||
Stockholders’ equity:
|
||||||||
Preferred stock; $0.01 par value; authorized shares 40,000,000; issued and outstanding shares -0-
|
-
|
-
|
||||||
Common stock, voting, $0.01 par value; authorized shares, 190,000,000; issued and outstanding shares - 19,540,593 at September 30, 2018, and 19,210,633 at December 31, 2017
|
195
|
192
|
||||||
Common stock, nonvoting, $0.01 par value; authorized shares, 10,000,000; issued and outstanding shares -0-
|
-
|
-
|
||||||
Additional paid-in capital
|
110,074
|
103,640
|
||||||
Accumulated other comprehensive loss
|
(3,681
|
)
|
(2,973
|
)
|
||||
Accumulated deficit
|
(29,599
|
)
|
(47,535
|
)
|
||||
Total stockholders’ equity
|
76,989
|
53,324
|
||||||
Total liabilities and stockholders’ equity
|
$
|
336,331
|
$
|
282,277
|
Three Months Ended
September 30, |
||||||||
2018
|
2017
|
|||||||
Net sales
|
$
|
83,349
|
$
|
73,340
|
||||
Cost of sales
|
47,138
|
40,372
|
||||||
Gross profit
|
36,211
|
32,968
|
||||||
Selling, general, and administrative expenses
|
23,253
|
18,534
|
||||||
Operating income
|
12,958
|
14,434
|
||||||
Interest expense
|
3,836
|
4,027
|
||||||
Interest income
|
(134
|
)
|
(4
|
)
|
||||
Investment income
|
(89
|
)
|
(131
|
)
|
||||
Net periodic benefit (income) expense, excluding service cost
|
(45
|
)
|
58
|
|||||
Income before income taxes
|
9,390
|
10,484
|
||||||
Income tax expense
|
1,436
|
3,110
|
||||||
Consolidated net income
|
$
|
7,954
|
$
|
7,374
|
||||
Basic income per common share:
|
||||||||
Consolidated net income
|
$
|
0.41
|
$
|
0.39
|
||||
Diluted income per common share:
|
||||||||
Consolidated net income
|
$
|
0.40
|
$
|
0.38
|
||||
Weighted average common shares outstanding:
|
||||||||
Basic
|
19,378,054
|
19,085,329
|
||||||
Diluted
|
19,882,994
|
19,589,424
|
Nine Months Ended
September 30, |
||||||||
2018
|
2017
|
|||||||
Net sales
|
$
|
238,392
|
$
|
212,214
|
||||
Cost of sales
|
134,577
|
119,508
|
||||||
Gross profit
|
103,815
|
92,706
|
||||||
Selling, general, and administrative expenses
|
66,314
|
53,764
|
||||||
Operating income
|
37,501
|
38,942
|
||||||
Interest expense
|
11,073
|
13,010
|
||||||
Interest income
|
(262
|
)
|
(8
|
)
|
||||
Investment income
|
(328
|
)
|
(334
|
)
|
||||
Loss on extinguishment of debt
|
2,384
|
6,116
|
||||||
Net periodic benefit expense, excluding service cost
|
176
|
174
|
||||||
Income before income taxes
|
24,458
|
19,984
|
||||||
Income tax expense
|
4,153
|
3,850
|
||||||
Consolidated net income
|
20,305
|
16,134
|
||||||
Net loss attributable to non-controlling interest
|
-
|
(556
|
)
|
|||||
Net income attributable to Turning Point Brands, Inc.
|
$
|
20,305
|
$
|
16,690
|
||||
Basic income per common share:
|
||||||||
Net income attributable to Turning Point Brands, Inc.
|
$
|
1.05
|
$
|
0.88
|
||||
Diluted income per common share:
|
||||||||
Net income attributable to Turning Point Brands, Inc.
|
$
|
1.03
|
$
|
0.86
|
||||
Weighted average common shares outstanding:
|
||||||||
Basic
|
19,290,096
|
18,915,606
|
||||||
Diluted
|
19,767,667
|
19,503,130
|
Three Months Ended
September 30,
|
||||||||
2018
|
2017
|
|||||||
Consolidated net income
|
$
|
7,954
|
$
|
7,374
|
||||
Other comprehensive income (loss), net of tax
|
||||||||
Amortization of unrealized pension and postretirement losses, net of tax of $3 in 2018 and $43 in 2017
|
10
|
71
|
||||||
Unrealized gain (loss) on investments, net of tax of $69 in 2018 and $8 in 2017
|
(231
|
)
|
12
|
|||||
Unrealized loss on interest rate swaps, net of tax of $70 in 2018
|
(233
|
)
|
-
|
|||||
(454
|
)
|
83
|
||||||
Consolidated comprehensive income
|
$
|
7,500
|
$
|
7,457
|
Nine Months Ended
September 30,
|
||||||||
2018
|
2017
|
|||||||
Consolidated net income
|
$
|
20,305
|
$
|
16,134
|
||||
Other comprehensive income (loss), net of tax
|
||||||||
Amortization of unrealized pension and postretirement losses, net of tax of $85 in 2018 and $132 in 2017
|
314
|
218
|
||||||
Unrealized gain (loss) on investments, net of tax of $173 in 2018 and $150 in 2017
|
(738
|
)
|
241
|
|||||
Unrealized loss on interest rate swaps, net of tax of $92 in 2018
|
(308
|
)
|
-
|
|||||
(732
|
)
|
459
|
||||||
Consolidated comprehensive income
|
19,573
|
16,593
|
||||||
Comprehensive loss attributable to non-controlling interest
|
-
|
(556
|
)
|
|||||
Comprehensive income attributable to Turning Point Brands, Inc.
|
$
|
19,573
|
$
|
17,149
|
Nine Months Ended
September 30, |
||||||||
2018
|
2017
|
|||||||
Cash flows from operating activities:
|
||||||||
Consolidated net income
|
$
|
20,305
|
$
|
16,134
|
||||
Adjustments to reconcile net income to net cash provided by operating activities:
|
||||||||
Loss on extinguishment of debt
|
2,384
|
6,116
|
||||||
Loss on sale of property, plant, and equipment
|
-
|
17
|
||||||
Depreciation expense
|
1,596
|
1,192
|
||||||
Amortization of other intangible assets
|
557
|
527
|
||||||
Amortization of deferred financing costs
|
712
|
768
|
||||||
Amortization of original issue discount
|
-
|
66
|
||||||
Deferred income taxes
|
2,806
|
1,847
|
||||||
Stock compensation expense
|
1,056
|
498
|
||||||
Changes in operating assets and liabilities:
|
||||||||
Accounts receivable
|
(3,192
|
)
|
(779
|
)
|
||||
Inventories
|
(18,840
|
)
|
(970
|
)
|
||||
Other current assets
|
(5,971
|
)
|
2,383
|
|||||
Other assets
|
144
|
(105
|
)
|
|||||
Accounts payable
|
4,442
|
(2,292
|
)
|
|||||
Accrued postretirement liabilities
|
(107
|
)
|
(18
|
)
|
||||
Accrued liabilities and other
|
(4,918
|
)
|
(4,993
|
)
|
||||
Net cash provided by operating activities
|
$
|
974
|
$
|
20,391
|
||||
Cash flows from investing activities:
|
||||||||
Capital expenditures
|
$
|
(1,528
|
)
|
$
|
(1,052
|
)
|
||
Restricted cash, MSA escrow deposits
|
(2,234
|
)
|
320
|
|||||
Acquisitions, net of cash acquired
|
(19,161
|
)
|
268
|
|||||
Issuance of note receivable
|
(6,500
|
)
|
-
|
|||||
Receipt of note receivable repayment including prepayment penalty
|
7,475
|
-
|
||||||
Net cash used in investing activities
|
$
|
(21,948
|
)
|
$
|
(464
|
)
|
Nine Months Ended
September 30,
|
||||||||
2018
|
2017
|
|||||||
Cash flows from financing activities:
|
||||||||
Proceeds from (payments of) 2018 first lien term loan, net
|
$
|
156,000
|
$
|
-
|
||||
Proceeds from 2018 second lien term loan
|
40,000
|
-
|
||||||
Proceeds from 2018 revolving credit facility
|
30,000
|
-
|
||||||
Payment of dividends
|
(1,537
|
)
|
-
|
|||||
Proceeds from (payments of) 2017 first lien term loans, net
|
(140,613
|
)
|
142,075
|
|||||
Proceeds from (payments of) 2017 second lien term loan, net
|
(55,000
|
)
|
55,000
|
|||||
Proceeds from (payments of) 2017 revolving credit facility, net
|
(8,000
|
)
|
15,550
|
|||||
Payments of VaporBeast Note Payable
|
(2,000
|
)
|
-
|
|||||
Proceeds from release of restricted funds
|
1,107
|
-
|
||||||
Payments of financing costs
|
(3,286
|
)
|
(4,783
|
)
|
||||
Exercise of options
|
779
|
1,371
|
||||||
Payment to terminate acquired capital lease
|
(170
|
)
|
-
|
|||||
Payments of first lien term loan
|
-
|
(147,362
|
)
|
|||||
Payments of second lien term loan
|
-
|
(60,000
|
)
|
|||||
Payments of revolving credit facility
|
-
|
(15,083
|
)
|
|||||
Payments of Vapor Shark loans
|
-
|
(1,867
|
)
|
|||||
Prepaid equity issuance costs
|
-
|
(394
|
)
|
|||||
Surrender of options
|
-
|
(1,000
|
)
|
|||||
Redemption of options
|
(623
|
)
|
(1,740
|
)
|
||||
Distribution to non-controlling interest
|
-
|
(4
|
)
|
|||||
Net cash provided by (used in) financing activities
|
$
|
16,657
|
$
|
(18,237
|
)
|
|||
Net increase (decrease) in cash:
|
$
|
(4,317
|
)
|
$
|
1,690
|
|||
Cash, beginning of period:
|
||||||||
Unrestricted
|
2,607
|
2,865
|
||||||
Restricted
|
4,709
|
3,889
|
||||||
Total cash at beginning of period
|
7,316
|
6,754
|
||||||
Cash, end of period:
|
||||||||
Unrestricted
|
1,631
|
4,235
|
||||||
Restricted
|
1,368
|
4,209
|
||||||
Total cash at end of period
|
$
|
2,999
|
$
|
8,444
|
||||
Supplemental schedule of noncash investing activities:
|
||||||||
Issuance of shares for acquisition
|
$
|
5,292
|
$
|
-
|
· |
Level 1 – Inputs to the valuation methodology are unadjusted quoted prices for identical assets or liabilities in active markets at the measurement date.
|
· |
Level 2 – Inputs to the valuation methodology include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or
liabilities in inactive markets, inputs other than quoted prices that are observable for the asset or liability, and inputs that are derived principally from or corroborated by observable market data by correlation or other means.
|
· |
Level 3 – Unobservable inputs that reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date.
|
As of September 30, 2018
|
As of December 31, 2017
|
|||||||||||||||||||||||
Cost
|
Gross
Unrealized
Losses |
Estimated
Fair |
Cost
|
Gross
Unrealized
Losses |
Estimated
Fair
Value |
|||||||||||||||||||
Cash and cash equivalents
|
$
|
1,367
|
$
|
-
|
$
|
1,367
|
$
|
3,602
|
$
|
-
|
$
|
3,602
|
||||||||||||
U.S. Governmental agency obligations
|
||||||||||||||||||||||||
(unrealized loss position < 12 months)
|
3,181
|
(53
|
)
|
3,128
|
722
|
(17
|
)
|
705
|
||||||||||||||||
U.S. Governmental agency obligations
|
||||||||||||||||||||||||
(unrealized loss position > 12 months)
|
27,514
|
(2,084
|
)
|
25,430
|
27,733
|
(1,214
|
)
|
26,519
|
||||||||||||||||
$
|
32,062
|
$
|
(2,137
|
)
|
$
|
29,925
|
$
|
32,057
|
$
|
(1,231
|
)
|
$
|
30,826
|
As of
|
||||||||
September 30,
2018 |
December 31,
2017 |
|||||||
Less than one year
|
$
|
1,499
|
$
|
-
|
||||
One to five years
|
9,600
|
7,114
|
||||||
Five to ten years
|
15,141
|
17,662
|
||||||
Greater than ten years
|
4,455
|
3,679
|
||||||
Total U.S. Governmental agency obligations
|
$
|
30,695
|
$
|
28,455
|
Deposits as of
|
||||||||
Sales
Year
|
September 30,
2018 |
December 31,
2017 |
||||||
1999
|
$
|
211
|
$
|
211
|
||||
2000
|
1,017
|
1,017
|
||||||
2001
|
1,673
|
1,673
|
||||||
2002
|
2,271
|
2,271
|
||||||
2003
|
4,249
|
4,249
|
||||||
2004
|
3,714
|
3,714
|
||||||
2005
|
4,552
|
4,552
|
||||||
2006
|
3,847
|
3,847
|
||||||
2007
|
4,167
|
4,167
|
||||||
2008
|
3,364
|
3,364
|
||||||
2009
|
1,619
|
1,626
|
||||||
2010
|
406
|
406
|
||||||
2011
|
193
|
193
|
||||||
2012
|
199
|
199
|
||||||
2013
|
173
|
173
|
||||||
2014
|
143
|
143
|
||||||
2015
|
101
|
101
|
||||||
2016
|
81
|
81
|
||||||
2017
|
83
|
70
|
||||||
Total
|
$
|
32,063
|
$
|
32,057
|
Total purchase price
|
$
|
24,292
|
||
Adjustments to purchase price:
|
||||
Cash acquired
|
(391
|
)
|
||
Working capital
|
(245
|
)
|
||
Adjusted purchase price
|
23,656
|
|||
Assets acquired:
|
||||
Working capital
|
2,681
|
|||
Fixed assets
|
1,296
|
|||
Intangible assets
|
8,140
|
|||
Capital lease obligation
|
(169
|
)
|
||
Net assets acquired
|
11,948
|
|||
Goodwill
|
$
|
11,708
|
Fair Value
|
||||
Working capital
|
$
|
3,181
|
||
Fixed assets
|
498
|
|||
Trade name
|
1,121
|
|||
Total purchase price
|
$
|
4,800
|
Vapor Supply
and IVG Actuals
|
Pro Forma Consolidated
|
|||||||||||
from Acquisition
Dates Through
|
Nine Months Ended
September 30,
|
|||||||||||
September 30, 2018
|
2018
|
2017
|
||||||||||
Net sales
|
$
|
9,737
|
$
|
281,679
|
$
|
270,795
|
||||||
Income (loss) before income taxes
|
(55
|
)
|
24,556
|
21,539
|
||||||||
Net income (loss)
|
$
|
(55
|
)
|
$
|
20,386
|
$
|
17,390
|
|||||
Basic earnings per common share:
|
||||||||||||
Net income
|
$
|
1.06
|
$
|
0.92
|
||||||||
Diluted earnings per common share:
|
||||||||||||
Net income
|
$
|
1.03
|
$
|
0.89
|
||||||||
Weight average common shares outstanding:
|
||||||||||||
Basic - inclusive of voting and non-voting shares
|
19,290,096
|
18,915,606
|
||||||||||
Diluted - inclusive of voting and non-voting shares
|
19,767,667
|
19,503,130
|
September 30,
2018 |
December 31,
2017
|
|||||||
Raw materials and work in process
|
$
|
3,285
|
$
|
2,545
|
||||
Leaf tobacco
|
34,873
|
30,308
|
||||||
Finished goods - Smokeless products
|
7,313
|
5,834
|
||||||
Finished goods - Smoking products
|
13,604
|
14,110
|
||||||
Finished goods - NewGen products
|
35,103
|
14,532
|
||||||
Other
|
722
|
1,290
|
||||||
94,900
|
68,619
|
|||||||
LIFO reserve
|
(5,467
|
)
|
(5,323
|
)
|
||||
$
|
89,433
|
$
|
63,296
|
September 30,
2018 |
December 31,
2017 |
|||||||
Land
|
$
|
22
|
$
|
22
|
||||
Buildings and improvements
|
2,320
|
2,072
|
||||||
Leasehold improvements
|
2,064
|
1,873
|
||||||
Machinery and equipment
|
13,275
|
12,635
|
||||||
Furniture and fixtures
|
4,601
|
3,821
|
||||||
22,282
|
20,423
|
|||||||
Accumulated depreciation
|
(11,697
|
)
|
(11,564
|
)
|
||||
$
|
10,585
|
$
|
8,859
|
September 30,
2018 |
December 31,
2017 |
|||||||
Inventory deposits
|
$ |
9,251
|
$ |
3,797
|
||||
Other
|
5,305
|
6,545
|
||||||
$
|
14,556
|
$
|
10,342
|
September 30,
2018 |
December 31,
2017 |
|||||||
Accrued payroll and related items
|
$
|
4,142
|
$
|
5,683
|
||||
Customer returns and allowances
|
2,353
|
2,707
|
||||||
Other
|
10,906
|
10,304
|
||||||
$
|
17,401
|
$
|
18,694
|
September 30,
2018 |
December 31,
2017 |
|||||||
2018 First Lien Term Loan
|
$
|
156,000
|
$
|
-
|
||||
2018 Second Lien Term Loan
|
40,000
|
-
|
||||||
Note payable - IVG
|
4,000
|
-
|
||||||
2017 First Lien First Out Term Loan
|
-
|
105,875
|
||||||
2017 First Lien Second Out Term Loan
|
-
|
34,738
|
||||||
2017 Second Lien Term Loan
|
-
|
55,000
|
||||||
Note payable - VaporBeast
|
-
|
2,000
|
||||||
Total notes payable and long-term debt
|
200,000
|
197,613
|
||||||
Less deferred finance charges
|
(3,471
|
)
|
(3,573
|
)
|
||||
Less current maturities
|
(8,000
|
)
|
(7,850
|
)
|
||||
$
|
188,529
|
$
|
186,190
|
Three Months Ended September 30,
|
||||||||||||||||
Pension
Benefits
|
Postretirement
Benefits |
|||||||||||||||
2018
|
2017
|
2018
|
2017
|
|||||||||||||
Service cost
|
$
|
26
|
$
|
26
|
$
|
-
|
$
|
-
|
||||||||
Interest cost
|
135
|
164
|
30
|
36
|
||||||||||||
Expected return on plan assets
|
(221
|
)
|
(256
|
)
|
-
|
-
|
||||||||||
Amortization of (gains) losses
|
33
|
114
|
(21
|
)
|
-
|
|||||||||||
Net periodic benefit (income) cost
|
$
|
(27
|
)
|
$
|
48
|
$
|
9
|
$
|
36
|
Nine Months Ended September 30,
|
||||||||||||||||
Pension
Benefits |
Postretirement
Benefits |
|||||||||||||||
2018
|
2017
|
2018
|
2017
|
|||||||||||||
Service cost
|
$
|
78
|
$
|
78
|
$
|
-
|
$
|
-
|
||||||||
Interest cost
|
419
|
484
|
88
|
108
|
||||||||||||
Expected return on plan assets
|
(728
|
)
|
(768
|
)
|
-
|
-
|
||||||||||
Amortization of (gains) losses
|
153
|
350
|
(61
|
)
|
-
|
|||||||||||
Curtailment loss
|
306
|
-
|
-
|
-
|
||||||||||||
Net periodic benefit cost
|
$
|
228
|
$
|
144
|
$
|
27
|
$
|
108
|
Stock
Option |
Weighted
Average |
Weighted
Average |
||||||||||
Outstanding, December 31, 2016
|
1,637,762
|
$
|
2.41
|
$
|
1.23
|
|||||||
Granted
|
133,819
|
14.69
|
4.41
|
|||||||||
Exercised
|
(923,708
|
)
|
1.55
|
0.83
|
||||||||
Forfeited
|
(801
|
)
|
15.37
|
4.59
|
||||||||
Surrendered
|
(83,400
|
)
|
1.06
|
0.54
|
||||||||
Outstanding, December 31, 2017
|
763,672
|
5.73
|
2.36
|
|||||||||
Granted
|
124,100
|
21.27
|
6.33
|
|||||||||
Exercised
|
(196,585
|
)
|
3.96
|
1.42
|
||||||||
Forfeited
|
(13,595
|
)
|
13.08
|
3.71
|
||||||||
Outstanding, September 30, 2018
|
677,592
|
$
|
8.95
|
$
|
3.33
|
February 10,
2017
|
May 17,
2017
|
March 7,
2018
|
March 13,
2018
|
|||||||||||||
Number of options granted
|
40,000
|
93,819
|
98,100
|
26,000
|
||||||||||||
Options outstanding at September 30, 2018
|
38,300
|
84,665
|
96,400
|
26,000
|
||||||||||||
Number exercisable at September 30, 2018
|
11,900
|
28,572
|
-
|
8,840
|
||||||||||||
Exercise price
|
$
|
13.00
|
$
|
15.41
|
$
|
21.21
|
$
|
21.49
|
||||||||
Remaining lives
|
8.37
|
8.63
|
9.44
|
9.46
|
||||||||||||
Risk free interest rate
|
1.89
|
%
|
1.76
|
%
|
2.65
|
%
|
2.62
|
%
|
||||||||
Expected volatility
|
27.44
|
%
|
26.92
|
%
|
28.76
|
%
|
28.76
|
%
|
||||||||
Expected life
|
6.000
|
6.000
|
6.000
|
5.495
|
||||||||||||
Dividend yield
|
-
|
-
|
0.83
|
%
|
0.82
|
%
|
||||||||||
Fair value at grant date
|
$
|
3.98
|
$
|
4.60
|
$
|
6.37
|
$
|
6.18
|
Three Months Ended September 30,
|
||||||||||||||||||||||||
2018
|
2017
|
|||||||||||||||||||||||
Income
|
Shares
|
Per
Share
|
Income
|
Shares
|
Per
Share
|
|||||||||||||||||||
Consolidated net income
|
$
|
7,954
|
$
|
7,374
|
||||||||||||||||||||
Basic EPS:
|
||||||||||||||||||||||||
Weighted average
|
19,378,054
|
$
|
0.41
|
19,085,329
|
$
|
0.39
|
||||||||||||||||||
Diluted EPS:
|
||||||||||||||||||||||||
Effect of dilutive securities:
|
||||||||||||||||||||||||
Stock options
|
504,940
|
504,095
|
||||||||||||||||||||||
19,882,994
|
$
|
0.40
|
19,589,424
|
$
|
0.38
|
Nine Months Ended September 30,
|
||||||||||||||||||||||||
2018
|
2017
|
|||||||||||||||||||||||
Income
|
Shares
|
Per
Share
|
Income
|
Shares
|
Per
Share
|
|||||||||||||||||||
Net income attributable to Turning Point Brands, Inc.
|
$
|
20,305
|
$
|
16,690
|
||||||||||||||||||||
Basic EPS:
|
||||||||||||||||||||||||
Weighted average
|
19,290,096
|
$
|
1.05
|
18,915,606
|
$
|
0.88
|
||||||||||||||||||
Diluted EPS:
|
||||||||||||||||||||||||
Effect of dilutive securities:
|
||||||||||||||||||||||||
Stock options
|
477,571
|
587,524
|
||||||||||||||||||||||
19,767,667
|
$
|
1.03
|
19,503,130
|
$
|
0.86
|
Three Months Ended
|
||||||||
September 30,
|
||||||||
2018
|
2017
|
|||||||
Net sales
|
||||||||
Smokeless products
|
$
|
21,743
|
$
|
21,294
|
||||
Smoking products
|
28,079
|
26,860
|
||||||
NewGen products
|
33,527
|
25,186
|
||||||
$
|
83,349
|
$
|
73,340
|
|||||
Gross profit
|
||||||||
Smokeless products
|
$
|
11,020
|
$
|
11,516
|
||||
Smoking products
|
14,814
|
14,201
|
||||||
NewGen products
|
10,377
|
7,251
|
||||||
$
|
36,211
|
$
|
32,968
|
|||||
Operating income (loss)
|
||||||||
Smokeless products (1)
|
$
|
4,114
|
$
|
6,036
|
||||
Smoking products (2)
|
8,595
|
8,958
|
||||||
NewGen products (3)
|
371
|
(535
|
)
|
|||||
Other (4)
|
(122
|
)
|
(25
|
)
|
||||
$
|
12,958
|
$
|
14,434
|
|||||
Interest expense
|
3,836
|
4,027
|
||||||
Interest income
|
(134
|
)
|
(4
|
)
|
||||
Investment income
|
(89
|
)
|
(131
|
)
|
||||
Net periodic benefit (income) expense, excluding service cost
|
(45
|
)
|
58
|
|||||
Income before income taxes
|
$
|
9,390
|
$
|
10,484
|
||||
Capital expenditures
|
||||||||
Smokeless products
|
$
|
251
|
$
|
446
|
||||
Smoking products
|
-
|
-
|
||||||
NewGen products
|
274
|
39
|
||||||
$
|
525
|
$
|
485
|
|||||
Depreciation and amortization
|
||||||||
Smokeless products
|
$
|
342
|
$
|
341
|
||||
Smoking products
|
-
|
-
|
||||||
NewGen products
|
343
|
255
|
||||||
$
|
685
|
$
|
596
|
|||||
(1) Includes allocated corporate charges of $1,748 and $1,734 for the three months ended September 30, 2018 and 2017, respectively.
|
||||||||
(2) Includes allocated corporate charges of $2,266 and $2,187 for the three months ended September 30, 2018 and 2017, respectively.
|
||||||||
(3) Includes allocated corporate charges of $2,168 and $2,061 for the three months ended September 30, 2018 and 2017, respectively.
|
||||||||
(4) “Other” includes the costs that are not assigned to the three reportable segments.
|
Nine Months Ended
|
||||||||
September 30,
|
||||||||
2018
|
2017
|
|||||||
Net sales
|
||||||||
Smokeless products
|
$
|
66,900
|
$
|
63,563
|
||||
Smoking products
|
84,403
|
81,056
|
||||||
NewGen products
|
87,089
|
67,595
|
||||||
$
|
238,392
|
$
|
212,214
|
|||||
Gross profit
|
||||||||
Smokeless products
|
$
|
34,546
|
$
|
32,385
|
||||
Smoking products
|
43,158
|
42,018
|
||||||
NewGen products
|
26,111
|
18,303
|
||||||
$
|
103,815
|
$
|
92,706
|
|||||
Operating income (loss)
|
||||||||
Smokeless products (1)
|
$
|
15,040
|
$
|
15,256
|
||||
Smoking products (2)
|
24,270
|
25,663
|
||||||
NewGen products (3)
|
(1,437
|
)
|
(1,916
|
)
|
||||
Other (4)
|
(372
|
)
|
(61
|
)
|
||||
$
|
37,501
|
$
|
38,942
|
|||||
Interest expense
|
11,073
|
13,010
|
||||||
Interest income
|
(262
|
)
|
(8
|
)
|
||||
Investment income
|
(328
|
)
|
(334
|
)
|
||||
Loss on extinguishment of debt
|
2,384
|
6,116
|
||||||
Net periodic benefit expense, excluding service cost
|
176
|
174
|
||||||
Income before income taxes
|
$
|
24,458
|
$
|
19,984
|
||||
Capital expenditures
|
||||||||
Smokeless products
|
$
|
1,140
|
$
|
973
|
||||
Smoking products
|
-
|
-
|
||||||
NewGen products
|
388
|
79
|
||||||
$
|
1,528
|
$
|
1,052
|
|||||
Depreciation and amortization
|
||||||||
Smokeless products
|
$
|
1,014
|
$
|
1,046
|
||||
Smoking products
|
-
|
-
|
||||||
NewGen products
|
1,139
|
672
|
||||||
$
|
2,153
|
$
|
1,718
|
|||||
(1) Includes allocated corporate charges of $6,010 and $5,324 for the nine months ended September 30, 2018 and 2017, respectively.
|
||||||||
(2) Includes allocated corporate charges of $7,585 and $6,789 for the nine months ended September 30, 2018 and 2017, respectively.
|
||||||||
(3) Includes allocated corporate charges of $6,948 and $5,662 for the nine months ended September 30, 2018 and 2017, respectively.
|
||||||||
(4) “Other” includes the costs that are not assigned to the three reportable segments.
|
September 30,
2018
|
December 31,
2017
|
|||||||
Assets
|
||||||||
Smokeless products
|
$
|
100,199
|
$
|
94,559
|
||||
Smoking products
|
141,129
|
141,869
|
||||||
NewGen products
|
94,020
|
44,914
|
||||||
Other (1)
|
983
|
935
|
||||||
$
|
336,331
|
$
|
282,277
|
(1) “Other” includes the assets that are not assigned to the three reportable segments. All goodwill has been allocated to the
reportable segments.
|
NewGen Segment
|
||||||||
Three Months Ended
|
||||||||
September 30,
|
||||||||
2018
|
2017
|
|||||||
Wholesalers
|
$
|
1,892
|
$
|
2,818
|
||||
Retail outlets
|
22,473
|
19,889
|
||||||
End-customers
|
9,162
|
2,479
|
||||||
$
|
33,527
|
$
|
25,186
|
NewGen Segment
|
||||||||
Nine Months Ended
|
||||||||
September 30,
|
||||||||
2018
|
2017
|
|||||||
Wholesalers
|
$
|
6,572
|
$
|
7,971
|
||||
Retail outlets
|
63,185
|
53,665
|
||||||
End-customers
|
17,332
|
5,959
|
||||||
$
|
87,089
|
$
|
67,595
|
Three Months Ended
September 30,
|
||||||||
2018
|
2017
|
|||||||
Domestic
|
$
|
78,529
|
$
|
69,484
|
||||
Foreign
|
4,820
|
3,856
|
||||||
Total
|
$
|
83,349
|
$
|
73,340
|
Nine Months Ended
September 30,
|
||||||||
2018
|
2017
|
|||||||
Domestic
|
$
|
226,826
|
$
|
203,210
|
||||
Foreign
|
11,566
|
9,004
|
||||||
Total
|
$
|
238,392
|
$
|
212,214
|
· |
Our ability to further penetrate markets with our existing products;
|
· |
Our ability to introduce new products and product lines that complement our core business;
|
· |
Decreasing interest in some tobacco products among consumers;
|
· |
Price sensitivity in our end-markets;
|
· |
Marketing and promotional initiatives, which cause variability in our results;
|
· |
General economic conditions, including consumer access to disposable income;
|
· |
Cost and increasing regulation of promotional and advertising activities;
|
· |
Cost of complying with regulation, including newly passed “deeming regulations”;
|
· |
Counterfeit and other illegal products in our end-markets;
|
· |
Currency fluctuations;
|
· |
Our ability to identify attractive acquisition opportunities in OTP; and
|
· |
Our ability to integrate acquisitions.
|
Three Months Ended September 30,
|
||||||||||||
2018
|
2017
|
% Change
|
||||||||||
Consolidated Results of Operations Data:
|
||||||||||||
Net sales
|
||||||||||||
Smokeless products
|
$
|
21,743
|
$
|
21,294
|
2.1
|
%
|
||||||
Smoking products
|
28,079
|
26,860
|
4.5
|
%
|
||||||||
NewGen products
|
33,527
|
25,186
|
33.1
|
%
|
||||||||
Total net sales
|
83,349
|
73,340
|
13.6
|
%
|
||||||||
Cost of sales
|
47,138
|
40,372
|
16.8
|
%
|
||||||||
Gross profit
|
||||||||||||
Smokeless products
|
11,020
|
11,516
|
-4.3
|
%
|
||||||||
Smoking products
|
14,814
|
14,201
|
4.3
|
%
|
||||||||
NewGen products
|
10,377
|
7,251
|
43.1
|
%
|
||||||||
Total gross profit
|
36,211
|
32,968
|
9.8
|
%
|
||||||||
Selling, general, and administrative expenses
|
23,253
|
18,534
|
25.5
|
%
|
||||||||
Operating income
|
12,958
|
14,434
|
-10.2
|
%
|
||||||||
Interest expense
|
3,836
|
4,027
|
-4.7
|
%
|
||||||||
Interest income
|
(134
|
)
|
(4
|
)
|
NM
|
|||||||
Investment income
|
(89
|
)
|
(131
|
)
|
-32.1
|
%
|
||||||
Net periodic benefit (income) expense, excluding service cost
|
(45
|
)
|
58
|
NM
|
||||||||
Income before income taxes
|
9,390
|
10,484
|
-10.4
|
%
|
||||||||
Income tax expense
|
1,436
|
3,110
|
-53.8
|
%
|
||||||||
Consolidated net income
|
$ |
7,954
|
$ |
7,374
|
7.9
|
%
|
Nine Months Ended September 30,
|
||||||||||||
2018
|
2017
|
% Change
|
||||||||||
Consolidated Results of Operations Data:
|
||||||||||||
Net sales
|
||||||||||||
Smokeless products
|
$
|
66,900
|
$
|
63,563
|
5.2
|
%
|
||||||
Smoking products
|
84,403
|
81,056
|
4.1
|
%
|
||||||||
NewGen products
|
87,089
|
67,595
|
28.8
|
%
|
||||||||
Total net sales
|
238,392
|
212,214
|
12.3
|
%
|
||||||||
Cost of sales
|
134,577
|
119,508
|
12.6
|
%
|
||||||||
Gross profit
|
||||||||||||
Smokeless products
|
34,546
|
32,385
|
6.7
|
%
|
||||||||
Smoking products
|
43,158
|
42,018
|
2.7
|
%
|
||||||||
NewGen products
|
26,111
|
18,303
|
42.7
|
%
|
||||||||
Total gross profit
|
103,815
|
92,706
|
12.0
|
%
|
||||||||
Selling, general, and administrative expenses
|
66,314
|
53,764
|
23.3
|
%
|
||||||||
Operating income
|
37,501
|
38,942
|
-3.7
|
%
|
||||||||
Interest expense
|
11,073
|
13,010
|
-14.9
|
%
|
||||||||
Interest income
|
(262
|
)
|
(8
|
)
|
NM
|
|||||||
Investment income
|
(328
|
)
|
(334
|
)
|
-1.8
|
%
|
||||||
Loss on extinguishment of debt
|
2,384
|
6,116
|
-61.0
|
%
|
||||||||
Net periodic benefit expense, excluding service cost
|
176
|
174
|
1.1
|
%
|
||||||||
Income before income taxes
|
24,458
|
19,984
|
22.4
|
%
|
||||||||
Income tax expense
|
4,153
|
3,850
|
7.9
|
%
|
||||||||
Consolidated net income
|
20,305
|
16,134
|
25.9
|
%
|
||||||||
Net loss attributable to non-controlling interest
|
-
|
(556
|
)
|
NM
|
||||||||
Net income attributable to Turning Point Brands, Inc.
|
$
|
20,305
|
$
|
16,690
|
21.7
|
%
|
(in thousands)
|
Three Months Ended
September 30,
|
|||||||
2018
|
2017
|
|||||||
Consolidated net income
|
$
|
7,954
|
$
|
7,374
|
||||
Add:
|
||||||||
Interest expense
|
3,836
|
4,027
|
||||||
Interest income
|
(134
|
)
|
(4
|
)
|
||||
Income tax expense
|
1,436
|
3,110
|
||||||
Depreciation expense
|
479
|
421
|
||||||
Amortization expense
|
206
|
175
|
||||||
EBITDA
|
$
|
13,777
|
$
|
15,103
|
||||
Components of Adjusted EBITDA
|
||||||||
LIFO adjustment (a)
|
201
|
(641
|
)
|
|||||
Pension/postretirement expense (b)
|
(18
|
)
|
84
|
|||||
Stock options, restricted stock, and incentives expense (c)
|
367
|
226
|
||||||
Foreign exchange hedging (d)
|
70
|
-
|
||||||
Strategic initiatives (e)
|
1,126
|
219
|
||||||
New product launch costs (f)
|
545
|
566
|
||||||
Product line rationalizations (g)
|
301
|
314
|
||||||
Organizational development (h)
|
98
|
-
|
||||||
Adjusted EBITDA
|
$
|
16,467
|
$
|
15,871
|
(a) |
Represents expense related to an inventory valuation allowance for last-in, first-out (“LIFO”) reporting.
|
(b) |
Represents our non-cash Pension/postretirement expense.
|
(c) |
Represents non-cash stock options, restricted stock and incentives expense.
|
(d) |
Represents non-cash gain and loss stemming from our foreign exchange hedging activities.
|
(e) |
Represents the fees incurred for the study of strategic initiatives and acquisition expenses.
|
(f) |
Represents product launch costs of our new product lines.
|
(g) |
Represents costs associated with discontinued products related to product line rationalization.
|
(h) |
Represents costs associated with departmental restructuring.
|
(in thousands)
|
Nine Months Ended
September 30,
|
|||||||
2018
|
2017
|
|||||||
Net income attributable to Turning Point Brands, Inc.
|
$
|
20,305
|
$
|
16,690
|
||||
Add:
|
||||||||
Interest expense
|
11,073
|
13,010
|
||||||
Interest income
|
(262
|
)
|
(8
|
)
|
||||
Loss on extinguishment of debt
|
2,384
|
6,116
|
||||||
Income tax expense
|
4,153
|
3,850
|
||||||
Depreciation expense
|
1,596
|
1,192
|
||||||
Amortization expense
|
557
|
526
|
||||||
EBITDA
|
$
|
39,806
|
$
|
41,376
|
||||
Components of Adjusted EBITDA
|
||||||||
LIFO adjustment (a)
|
144
|
246
|
||||||
Pension/postretirement expense (b)
|
254
|
252
|
||||||
Stock options, restricted stock, and incentives expense (c)
|
1,056
|
446
|
||||||
Foreign exchange hedging (d)
|
70
|
(90
|
)
|
|||||
Product line rationalizations (e)
|
1,309
|
314
|
||||||
Strategic initiatives (f)
|
2,755
|
990
|
||||||
New product launch costs (g)
|
1,227
|
1,727
|
||||||
Organizational development (h)
|
778
|
-
|
||||||
Adjusted EBITDA
|
$
|
47,399
|
$
|
45,261
|
(a) |
Represents expense related to an inventory valuation allowance for last-in, first-out (“LIFO”) reporting.
|
(b) |
Represents our non-cash Pension/postretirement expense.
|
(c) |
Represents non-cash stock options, restricted stock and incentives expense.
|
(d) |
Represents non-cash gain and loss stemming from our foreign exchange hedging activities.
|
(e) |
Represents costs associated with discontinued products related to product line rationalization.
|
(f) |
Represents the fees incurred for the study of strategic initiatives and acquisition expenses.
|
(g) |
Represents product launch costs of our new product lines.
|
(h) |
Represents costs associated with departmental restructuring.
|
As of
|
||||||||
(in thousands)
|
September 30,
2018
|
December 31,
2017
|
||||||
Current assets
|
$
|
112,223
|
$
|
79,493
|
||||
Current liabilities
|
64,161
|
38,230
|
||||||
Working capital
|
$
|
48,062
|
$
|
41,263
|
(in thousands)
|
September 30,
2018
|
December 31,
2017
|
||||||
2018 Revolving Credit Facility
|
$
|
30,000
|
$
|
-
|
||||
2018 First Lien Term Loan
|
156,000
|
-
|
||||||
2018 Second Lien Term Loan
|
40,000
|
-
|
||||||
Note payable - IVG
|
4,000
|
-
|
||||||
2017 Revolving Credit Facility
|
-
|
8,000
|
||||||
2017 First Lien First Out Term Loan
|
-
|
105,875
|
||||||
2017 First Lien Second Out Term Loan
|
-
|
34,738
|
||||||
2017 Second Lien Term Loan
|
-
|
55,000
|
||||||
Note payable - VaporBeast
|
-
|
2,000
|
||||||
230,000
|
205,613
|
|||||||
Less deferred financing charges
|
(3,471
|
)
|
(3,573
|
)
|
||||
Less revolving credit facility
|
(30,000
|
)
|
(8,000
|
)
|
||||
Less current maturities of long-term debt
|
(8,000
|
)
|
(7,850
|
)
|
||||
Notes payable and long-term debt
|
$
|
188,529
|
$
|
186,190
|
Payments due by period as of September 30, 2018
|
||||||||||||||||||||
Total
|
Less than 1
year
|
1-3 years
|
4-5 years
|
More than 5
years
|
||||||||||||||||
Long-term debt obligations, including interest
|
$
|
280,795
|
$
|
51,969
|
$
|
44,632
|
$
|
142,600
|
$
|
41,594
|
Payments due by period as of December 31, 2017
|
||||||||||||||||||||
Total
|
Less than 1
year
|
1-3 years
|
4-5 years
|
More than 5
years
|
||||||||||||||||
Long-term debt obligations, including interest
|
$
|
266,052
|
$
|
29,803
|
$
|
42,444
|
$
|
193,805
|
$
|
-
|
Exhibit No.
|
Description
|
International Vapor Group Stock Purchase Agreement dated as of September 5, 2018, between Turning Point Brands, Inc. and International
Vapor Group, LLC.*+
|
|
Rule 13a-14(a)/15d-14(a) Certification of Lawrence S. Wexler.*
|
|
Rule 13a-14(a)/15d-14(a) Certification of Robert Lavan.*
|
|
Rule 13a-14(a)/15d-14(a) Certification of Brian Wigginton.*
|
|
Section 1350 Certifications pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.*
|
|
101
|
XBRL (eXtensible Business Reporting Language). The following materials from Turning Point Brands, Inc.’s Quarterly Report on Form 10-Q for the quarter
ended September 30, 2018, filed on November 7, 2018, formatted in XBRL: (i) consolidated balance sheets, (ii) consolidated statements of income, (iii) consolidated statements of comprehensive income, (iv) consolidated statements of cash
flows, and (v) the notes to consolidated financial statements.*
|
* |
Filed or furnished herewith
|
+ |
Certain schedules, appendices and exhibits to this agreement have been omitted in accordance with Item 601(b)(2) of Regulation S-K.
A copy of any omitted schedule and/or exhibit will be furnished supplementally to the Securities and Exchange Commission staff upon request.
|
TURNING POINT BRANDS, INC.
|
||
By: /s/ Lawrence S. Wexler
|
||
Name: Lawrence S. Wexler
|
||
Title: President and Chief Executive Officer
|
||
By: /s/ Robert Lavan
|
||
Name: Robert Lavan
|
||
Title: Chief Financial Officer
|
||
By: /s/ Brian Wigginton
|
||
Name: Brian Wigginton
|
||
Title: Chief Accounting Officer
|